Clinical Trial Update: Of 18F MEL050 Using PET/CT in Metastatic Melanoma [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update on the early-phase study of the PET radiotracer 18F MEL050 used with PET/CT in metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• 18F MEL050 (18F-MEL050 radiotracer)

Snippet

Sponsor: Cooperative Research Centre for Biomedical Imaging Development | Conditions: Metastatic Melanoma | EARLY_Phase 1 | Status: UNKNOWN